AMC Networks Inc. Reports Third Quarter 2025 Results

AMC Networks Inc. Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the third quarter ended September 30, 2025. Chief Executive Officer Kristin Dolan said: “Our performance in the third quarter marks […]

Whitestone REIT Acquires Primely Located World Cup Plaza in Frisco, Texas

Whitestone REIT Acquires Primely Located World Cup Plaza in Frisco, Texas GlobeNewswire November 07, 2025 Center located adjacent to the 21,000-seat Toyota Stadium that attracts more than 1.4 million visitors annually and will serve as a base camp for the 2026 FIFA World Cup Property strategically situated at the busiest intersection north of 121 and

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado's A2B and A2A Receptor Antagonists and Cancer Vaccines Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITC GlobeNewswire November 07, 2025 Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE)

Lagoon Furniture at BDNY 2025 | Stylish & Durable Hospitality Design

Lagoon Furniture at BDNY 2025 | Stylish & Durable Hospitality Design Discover Lagoon Furniture's premium outdoor and hospitality collections at BDNY 2025. Explore durable, design-forward pieces for hotels, bars, and resorts. GlobeNewswire November 07, 2025 New York, NY, Nov. 07, 2025 (GLOBE NEWSWIRE) — Lagoon Furniture makes its official debut at BDNY 2025, unveiling a

Agricultural Robots Market worth $56.26 billion by 2030- Exclusive Report by MarketsandMarkets™

According to MarketsandMarkets™,The agricultural robots market is estimated at USD 17.73 billion in 2025 and is projected to reach USD 56.26 billion by 2030, at a CAGR of 26.0% from 2025 to 2030. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg The agricultural robots market is driven by the growing adoption of automation and precision farming solutions, which aim to improve operational

Perella Weinberg Reports Third Quarter 2025 Results

(NASDAQ:PWP), Financial Overview – Third Quarter Revenues of $165 Million, Down 41% From a Record a Year Ago Adjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.13; GAAP Diluted EPS of $0.08 Financial Overview – Nine Months Revenues of $532 Million, Down 18% From a Record a Year

NYU Langone Cardiologists Share Leading Research at AHA Scientific Sessions 2025 & Dr. Judith S. Hochman Honored with Research Achievement Award

Expert researchers and clinicians from the Leon H. Charney Division of Cardiologyat NYU Langone will present practice-changing studies, translational research, and clinical insights at the 2025 American Heart Association's (AHA's) Scientific Sessions, held from November 7 to 10 in New Orleans. Topics include diving into inflammation's role in heart disease, management of a type of

Perella Weinberg Reports Third Quarter 2025 Results

Perella Weinberg Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 Financial Overview – Third Quarter Revenues of $165 Million, Down 41% From a Record a Year Ago Adjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.13; GAAP Diluted EPS of $0.08 Financial Overview – Nine Months Revenues

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ILIOCAVAL OBSTRUCTION

The investigational device evaluated in the trial, previously known as the GORE® VIAFORT Vascular Stent, will now be referred to as the GORE® VIABAHN® FORTEGRA Venous Stent. CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates' medical business (Gore) today announced trial results evaluating the investigational GORE® VIABAHN®

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Terms of Rights Offering, Announces December Monthly Distribution and Provides Update on Capital Gains

The board of trustees (the “Board”) of NXG Cushing® Midstream Energy Fund (NYSE: SRV) (the “Fund”) has approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund's common shares (the “Common Shareholders”) of beneficial interest, par value $0.001 per share (“Common Shares”), as of the record date, entitling the

Scroll to Top